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restudy. In control group, no anti-hyperlipidemic drug was administered. One
PTCA region of intereat par patient was spaeified at registration and was
analysed in a core laboratory by quantitative Coronaryangiography (QCA).
Restenosis was defined as a recurrent Iuminal stenosis of more than 50%
in the dilated segment at the time of restudy. Seventy eight patients (40
for Probucol and 38 for control) completed the study and restenosie rate in
Probucol group was Significantly IOWerthan in COfWOl group (23% vs 57%,
p < 0.01). Subjects were divided into =- 2.7 mm (n= 41) and s 2.7 mm (n
= 37) subgroups acmrding to reference diamater. The results of QCA were
shown in the table.
Reference vessel s 2.7 mm > 2,7mm
(mm) Probucol control Probucol control
Acute geln 0.99+ 0.32 0.97 + 0.37 n.e. 1.30 + 0.47 t.16 + 0.63 n,s,
Late10-S 0.20 + 0.43 0.78 + 0.57 p <0.01 0.54+ 0.67 0.46+ 0.63 n.e.
Net gain 0.79 + 0.46 0.19 + 0.55 p <0.01 0.75+ 0.91 0.69+ 0.54 n.s.
In patients with a reference vessel >2.7 mm, restenoeie rate was 217. in
Probucol group and 45Y0in COntrOlgroup (n.s.). However in thes 2.7 mm
subgroup, restenosis rate in Probueol group was 24%, significantly lower
than in Controlgroup, 75% (p < 0.01).
/n conclusion, Probucol administered for 4 weeks prior to PTCA was
effaetivein preventing restenosis after PTCA in corona~ arteriess 2.7 mm.
11038-741 Effects of Lovaststinon Rastenosisafter PTCA
and on Progression of Coronary Artery Disease.
The Cholesterol Lowering Atherosclerosis PTCA
Trial (CLAPT)
A. Kleemann ‘,6, S. Ecker12,A.v. Eckardstein6, W. Leppers,
U. Schemikau4, U. Gleichmann2, P.Hanrath3, E. Flack4, A. Neiss5,
G. Assmanne, G. Breithardt 1,8for the CLAPT Study Group. 1Dpt. of
Cardiolog~ Urrht of Mfinstec GerrnarrB2 Dpt. of CardioiogK Bochurrr/Bad
Oeynhausen, Germanx 3Dpt. of Cardiology, Aachen, Mtinstefi Germsn~
4 Dpt. of Cardiolog~ German Heart Institute Berfin, Gerrnarr~5 IMSE, TU
Munich, Germarr~ 6 Institute for Arteriosclerosis Research, Miinstec
Gamrany
CLAPT ia a multicenter, prospective, randomized trial to assess the effect
of a 2-year treatment with Iovastatin on restanosis after PTCA and non-
dilated coronary sagrnents (=-20% degree stenosis). Loveetatin was atarted
4 weeks prior to PTCA. Main inclusion criteria were cholesterol 200-300
mg/dl, triglycerides -=250 mg/dl, age 18 to 70 yeara and the presence of at
least 1 additional coronary lesion > ’20% beside the stenosis scheduled for
PTCA. Main exclusion criteria were unstable angina, coronary arlery bypasa
grafts and previous PTCA. During 1991 to 1994, 228 male patienta were
randomized 4 weeka prior to PTCA to usual care [UC] (diet; n = 114; age
53.7; BMI 26.4 kdmz) or special care [SC] (diet plus Iovastetin; n = 112;
age 54.1; BMI 25.9 kg/m2). Lovaetatin was titrated during follow-up visits
to attain a serum LDL-cholesterol < 120 mddl. Total- (SC/UC: 242/248
mgfdl) and LDL-cholesterol (SC/UC: 17S/179 m@dl)decreased by 21% and
27% in the Iovastatin treatad group and by 5% and 5% in the usual Care
patienta after 4 months. Quantitative coronaty angiography wea performed
at baseline (PTCA) and repeated after 4 and 24 months. Analysis of the
baseline and follow-up Coronaw arIeriograms waa carried out byquantitetive
eomputar analysis on blinded cinefilms. 92% and 71% of the patients had a
4-month and 24-month coronav angiogram, reepeetively. Prfmaty endpoint
was the change of the mean segment diameter of non-dilated segments
averaged per patient. One secondary endpoint was to compare the change
of the minimal lesion diameters averaged par patient between dilated and
non-dilatadsegments. The detailed results will be presentad.
m103875 TranilestPreventsRestenosisAfterDirectionalCoroneryAtherectomyMoreStronglyinLarger
SizedVessels
K. Kosuga, H. Tamai, K.Uada,Y.-S.Hsu,S.One,S.Tanaka,S. Matsui,
M.Minami,S. Motohare,H.Uehate.Shiga Medical CentarforAdu/t
Diseases, Morfyama, Japan
Tranilast,an anti-allergicdrug, preventsrestenosisafter PTCA(TREAT
study).We estimatedthe effactiveneasof tranilaston preventingresteno-
sis afterdirectionalcoronaryatheractomy(DCA)accordingto vesselsize.
Aftertheprocedure,39 patients(60Ie$ions,trenilastgroup)weretreatadby
oraltreniiastfor 3 months,and 143patienta(178lesions,controlgroup)did
not receivedit. Accordingto referencevesaelsize,the Iesioneweredivided
intotwoaubgroups;>3 mm group (30 lesions each in either group) and -=3
mm group (89Ieeionain trenilastgroupand87 lesionsin thecontrolgroup).
Therewas no differencein baseline charaeteristiea between the trenilast
and control group, clinically and angiogrephically. The initial and 3-month
follow-up angiograms were examined in both groups. Angiographic analyses
were performed with QCA, and restenosis was defined as > 50’% atenosis
at 3-month follow-up. Results are as follows:
Subgroup Tranilaat(n = 60) Control (n= 176) p value
3-monthatenoaia < 3mm 30& 25 43 k 24
(%)
p <0.05
z 3mm 27& 16 36& 22 p <0.01
3-monthMLD <3 mm 1.79 + 0.73 1.51 + 0.69
(mm)
p = 0.06
23 mm 2.39 h 0.57 1,99 * 0.70 p <0.01
reatanoaiarate < 3mm 20,0 31,5 n.a.
(“/6) 23 mm 3,3 20,7 p <0.05
Conclusion: Tranilast improves both 3-month stenosis and 3-month MLD
after DCA in < 3 mm group as well as in z 3 mm group. Furthermore its
prevents restenosis at 3-month follow-up more strongly in z 3 mm group.
Tranilast after DCA is encouraging therapy for corona~ artery dieease.
11038-761 LOCa!Appiir2atiOnof PaclitaxelVVith the Double
Balloon Catheter in the Rabbit Carotid Artery
C. Herdeg, M. Oberhoff, A. Baumbach, W. Kunett, K.R. Karsch. Univareify
of Tuebingen,Germany
Paclitexel (Texol@)is a new microtubule stabilizing drug with potent antitumor
activity. It influences the eytoskeleton equilibrium by increasing the aasembly
of stable microtubules and thereby intereets with many cellular functions.
The aim of this study was to evaluate the potential of paclitexel to prevent
restenosis in vivo. After induction of a defined plaque formation in the dght
carotid afterfee of 66 New Zealand rabbite by elaetrieel stimulation, 27 ani-
mala underwent balloon dilatation and subsequent local paclitaxel delivety of
10 ml paclitexel (10 ~mol/L) with the double balloon. 29 animals sewed as
control with angioplasty only and 10 animals were eolely eleetrostimulated.
Vessels were excised 1, 4 and 8 weeks following intervention. lmmunohis-
tologieel staining with antibodies against bromodeoxyuridine, alpha-aetin,
macrophages, von Willebrandt factor and tubulin wae performed. Electron
microscopy served for the detection of cytoskeletd changes.
Ffesu/ts.’Corresponding to a strong decrease in earfy intimal proliferation
the intimal area in paclitexel treated animals increaead only minimally during
the obaetvation period from 0.179 mmz (1 weak) to 0.193 mmz (8 weeks). In
control animals the intimal area increaeedconsiderably to O.301mmz8weeks
after intervention. Marked vessel enlargement compared to control animals
could be obeerved at any time point (Luminal area 8 weeks after intervention:
paclitaxel group: 0.754 mmz, control: 0.417 mmz). Tubulin staining revealed
changes in microtubule assembly which were atrictly limited to the intimal
area.
Conclusion: Local peclitexel delive~ proved safe and effective in this
animal model both by reduction of neointima formation and enlargement in
veeeel size. Thus, the application of the highly Iipophilic paclitaxel via the
double balloon may be a promising approach for local therapy of restenosis.
Eil The Role of Endotheiium and Extracellular
Matrix in Restenosis
Wednesday,March 19, 1997, 9:00 a.m.-n :00 a.m.
AnaheimConventionCenter,Hall E
Presentation Hour: 10:00 a.m.–n :00 a.m.
I1039-93/uaeOfVet’yLateAntigen-4 (VLA-4)hItegrin
Binding Blockade with Connecting Segment-1
Peptide in Prevention of Restenosis After Bslloon
Angioplasty in the Rabbit Atherosclerotic Model
M.J. Silver, D.L. Smull, F. Forudi, K.A. Bucknell, E.J. Topol, A.M. Lineoff.
Cleveland Clinic, C/eve/arid, OH, USA
VLA-4 blockade has been shown to favorably reduce neointimal prolif-
eration in experimental modele of transplant mronaty arteriopathy. The
tranaendothelial trafficking of inflammato~ cells is similar following arle-
rial injury with balloon angioplasty. We hypothesized that blocking VLA-4
and endothelial cell interaction would limit naointimal proliferation following
arterial injury in the rabbit atherosclerotic model. The femoral arteriea of 20
New Zealand white rebbita underwent induction of focal atherosclerosis us-
ing air desieeetion followed by a 4 week atherogenic diet. Arterial injury was
then performed using a 2 mm angioplasty ballocmat 8 atm for 60 seconds.
Animals were randomized to receive the VIA-4 blocker (1 mg/kg SC) or
placebo 12 hours before arterial injuty and daily for 1 week. Three weeks
following arterial injury, the arteries were hatvested and histologiesdanalysis
was performed. IBDA.l.
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VIA-4 (n= 16) Placebo(n= 15) P
Lumen(mmz) 0.16 0.23 0.75
Media(mmz) 0.21 0.21 0.52
Intima(mmz) 0.29 0.36 0.30
% Intima 0.59 0.61 0.60
Conclusion.’ Despite iks ability to limit neointimal proliferation in trans-
plant arteriopathy, VLA-4 blockade at the current dose has no significant
effect on limiting neointimal proliferation following arterial injuty in the rabbit
atherosclerotic model.
1039-94 Effect of Latent Cytomegalovirus Infection of Rats
on theNeointimal Response to Vascular Balloon
Injury
Y.F.Zhou, M. Shou, R.L. Harrell, E.F. Unger, T. Finkel, S.E. Epstein.
National Institutes ofl-lealth, Bethesda, MD, USA
We recently found that prior cytomegalovirus (CMV) infection is a rick factor
for restenoeis after angioplasty, and acute infection of rats with rat CMV
(RCMV), 1 day after carotid injury, increases neointimal accumulation. We
hypothesized that vaaeularinjury reactivates /aterrtCMV;the reactivatedvirus
then exacerbates the neointimal response to injury. Thus, to more critically
testthe CMV/restenosis hypothesis, wemeasuredthe neointimal responseto
carotid injury following latent RCMV infection. Sixty newborn male Sprague-
Dawley rats (3 wks old) were randomized into two groups and received
an ip injection of either 106active RCMV viral particletiml or saline. Carotid
balloon injury was performed 3 mos after infection, when nosignsof infection
were evident. Rats were sacrificed 6 wks later. Vessele were petfueion-
fixed, cut into 3-5 segmenta, paraffin embedded, and stained by the Movat
pentachrome method. The section with the greatest Iuminal narrowing was
planimeterizad and normalized by expressing the results as the neointima
to media (N/M) ratio. We found that the N/M ratio of rats latently infected
with CMV was 41Y0greater than uninfected controls (mean + SD: 1.40 +
0.48 vs 0.99 * 0.45, respectively: P= 0.003). The results were similar when
analyzed as% StenOSiS(44 + 13% vs 32 + 14%, respectively; P = 0.003).
We conclude that.CMV has the genetic program that can cause exceasive
neointimal accumulation in response to vascular injuty. The results are also
compatible with our hypotheaie that arterial injury reactivates latent virus, an
event which then Ieada to cellular processes predisposing to restenoeis.
m103995 Restenosis is Highly Related to Collagen Content
and Fiber Organization in the Atherosclerotic
Rabbit Model
W.D. Coate, Jr., P.Whittakerl, D.T. Cheung, J.W. Currier, B. Han,
D.P. Faxon. University of Southern Ca/ifomia, Los Angeles, CA, USA,
1>The f-fear?hrstitute, The Hospital of the Good Samaritan, Los Angeles,
CA, USA
Prior atudies have shown that angioplaety stimulates an increase in both
synthesis and degradation of collagen in the atherosclerotic vessel, however,
differences in collagen content and metabolism between restenotic (R) and
nonrestenotic (N) vessels have not been examined. Accordingly, mllagen
content in 11 R and N vessels was measured four weeks after angioplasty
in an atherosclerotic rabbit model both biochemically by hydroxyproline (OH-
pro) quantitation and histologically by a digital subtraction method using
circularly polarized images of 20 picrosirius red stained sections. Qualitative
and quantitative histologic analysis of collagen fiber organization (CFO)was
also performed. Collagenase and gelatinate activities were measured in the
same R and N vessels ueing a radiosubstrate assay. Collagen content was
found to be lower in R vs N veseels.
CollagenContent R N P n
Blachemieslly(pgOH-pro/mgtissue) 127.0+ 32.6 212.6+ 64.3 <0.05 11
Histologically(“Aintimal+ medialarea) 67.3 & 7.9 76.3 + 11.6 =0.05 20
CFO in R veseela was Ieae coherent with loose, more radially aligned
fibere vs compacted, more circumferentially aligned fibers in N vessels. In N
vessels, 80Y0of collagen fibera were < 20g from tangential at the point of
measurement vs 54% in R vessels @ = 0.011; n = 50 fibers). There was a
correlation between lumen area and percent collagen content (p= 0.0071)
and an inverse correlation between collagen content and gelatinate aefivily
(p= 0.02). Thua, restenosis ia highly related to collagen content and CFO
which may be due to increased gelatinate activity.
I1039-96IEndOluminalVerSLfaPeriadVentitial DeliverY Of
Antifibronectin Antibodies. Implications for Local
Arterial Wall Delivery
J.-E. Fabre, J.-L. Samuel, L.J. Feldman, L. Rappaport, P.G.Steg. Faculte
Bichat & IMSERM U127, Paris, France
Periadventitial route has been suggested for drug delivery to the arterial
wall. Its ability to achieve effective delivery of antibodies (Ab) to the media
and intima is unknown. Total fibroneetin (FNt) is expressed in rat arterial
adventitia and intima. We compared endoluminal vs periadventitial delivev
of rabbit polyclonal (lgG) FNt Ab, diluted at 1/20 either in PBS or in pluronic
F127 (25% w/v). In 21 Sprague-Dawley rats, the left common carotid artety
was exposed. In 8, the pluronic solution containing the Ab was applied
onto the arterial adventitia and gelled instantly. In 13 other rata, endoluminal
delive~ was performed via a dwell method for 30 min. One day later, arterial
cryosectionswere incubated with fluorescent (Texasred) Ab against rabbit to
localise the FNt Ab. Controls included arteries either untreated or receiving
nonspeeificAb. Periadventitial delivery viathe pluronic gel resulted in labeling
of the outer adventitia, but not of the media. The pattern was unmodified by
periadventitial polyethylene wrapping or even adventitial stripping prior to
delivery. Conversely, endoluminal delivery resulted in consistent labeling of
the whole media, up to and including the adventitia. Kinetic etudies (5, 15
rein, 1, 3, 4 h) demonstrated progressive labeling of the media from the inner
to its outer layers within 4 h. Conclusion: endoluminal delivey is the route of
choice for Ab delivery to the arterial wall, achieving effective intimal, medial
and adventitial delivery within 24 h. Conversely, periadventitial delivering of
Ab donotallow medial penetration, whereae theendoluminal delivey appear
to be the route of choice for specific Ab delivery to the media.
1039-97 Upregulatad Aiterial Expression of the Eatrogen
Receptor After Balloon Injury: Role in TGF+J
Mediated Repair?
C. Hoffert, M. Labinaz, M.R. Garvin, K. Pels, E.R. O’Brien. Uniu Ottawa
Heari Instit., Offawe, Canada
Estrogens act through a specific receptor (ER), and are known to increase
TGF-B expression. In human atherosclerosis and restenosis we previously
documented the expression of Big-h3, aTGF-p inducible gene that may serve
as a biological marker of TGF-fJactivity. Purpose: Determine the arterial ex-
pression patterns of the ER and flig-h3 after corona~ artery angioplasty.
Porcine coronary arteries were harvested 3, 7, 14 and 28 days after angio-
plasty [balloon:artery = 1.5:1.0; single injury (Sl): n = 6; double injury (Dl): n=
6]. Six control arteriea were also studied. Proliferation, as aasessed by incor-
poration of BrDU, was most pronounced (14% of cells) in all arterial layers
on day 3 after SI and Dl, and primarily involvxi adventitial and intimal smooth
muscle cells (SMCS) and endothelial cells (ECS) of adventitial neovessela.
By day 28 after DI adventitial SMCSappeared to migrate inward. Using two
independent antibodies, ERs were immunoloeelized to the nuclei of a few
adventitial cells in normal arteries. In contrast, adventitial =-medial > intimal
SMCS over-expressed ERs with both cytoplasmic and nuclear distribution
pafferna early > late after SI and D1.Compared to normal arteries, Big-h3
mRNA and protein were also over-expressed in adventitial SMC and-EC
early > late after SI and D1.Conclusions.’Early after injury arterial expression
of the ER is unregulated and is associated with the expression of a TGF-r9
inducible gene. The significance of ER expression in the attery wall is cur-
rently being studied, as it may enhance TGF-6 expression and therefore, the
role of this growth factor in vascular repair.
I1039-98ILocal lnfuSiOnOfVaacu,ar Endothe,ia, Growth
Factor Following Coronary Angioplaaty in Swine
G.Gershony, M. Smyrl, J.M. Brock, N. Ferrara, J.S. Powell. University of
Caiifomia, Davis, Sacramento, CA, USA
The major limitation of PTCA is restenosis due to neointimal proliferation and
vascular remodeling which is believed to be the result of endothelial denuda-
tion and medial injury occurring at the time of angioplasfy. To investigate ths
hypothesis that accelerated reendothelialization would limit the proliferative
response to vascular injury, we initiated experiments in pige to bcally infuse
the endothelial-speoific mitogen, Vascular Endothelial GrowthFactor(V),fol-
lowingPTCA.LADcoronaryarteriesin 28domeaticpigs(weight38.7+ 5.6
kg)weresubjectedto PTCA (balloon/artery ratio 1.3:1) followed by infuaion
of saline in 15 animals or 0.5 mg of V in 13 animals for 30 min via a Imal drug
delivery oatheter(Dispatch’”). All animals receiving V experienced significant
systemic effects. The systolic blood presaure decreased by 33.7 + 8.0 mm
Hg within 5 min of initiating the V infusion requiring the use of pressora vs
6.8 +4.9 mm Hg for the controls (P < 0.0001). The P02 decreased by 165.6
+ 74.7 and 49.2 + 44.7 mm Hg for the V and control groups respectively
(p< 0.002). These systemic effects reaolvad within minutes of stopping the
